Phase 1 Plasmodium Falciparum Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Safety, Tolerability, Pharmacokinetics (including Food Effect) of Single Ascending Doses of SAR441121 in healthy male subjects.

Parasitic Diseases - Plasmodium falciparum infection

sanofi-aventis australia ptd ltd62 enrolled1 locationACTRN12618001783213

Recruiting

Phase 1

A Phase I, pharmacokinetic trial, in healthy Asian and Caucasian volunteers for investigating the pharmacokinetic profiles of Eurartesim (trademark) (40 mg Dihydroartemisinin/320 mg Piperaquine Phosphate)

Anti-Malarial Treatment of uncomplicated plasmodium falciparum malaria

CPR Pharma Services Pty Ltd20 enrolled1 locationACTRN12610000178044